LNA Santé 미래 성장

Future 기준 확인 2/6

LNA Santé is forecast to grow earnings and revenue by 7.5% and 8.8% per annum respectively. EPS is expected to grow by 6.6% per annum. Return on equity is forecast to be 7.9% in 3 years.

주요 정보

7.5%

수익 성장률

6.6%

EPS 성장률

Healthcare 수익 성장	21.5%
매출 성장률	8.8%
향후 자기자본 수익률	7.9%
애널리스트 커버리지	Low
마지막 업데이트	10 Oct 2024

최근 미래 성장 업데이트

Recent updates

Earnings Miss: LNA Santé SA Missed EPS By 48% And Analysts Are Revising Their Forecasts

Apr 03

Is LNA Santé SA's (EPA:LNA) 6.9% ROE Strong Compared To Its Industry?

Mar 17

Are Investors Undervaluing LNA Santé SA (EPA:LNA) By 50%?

Mar 02

At €47.80, Is It Time To Put LNA Santé SA (EPA:LNA) On Your Watch List?

Feb 16

Did Business Growth Power LNA Santé's (EPA:LNA) Share Price Gain of 102%?

Feb 04

Our Take On The Returns On Capital At LNA Santé (EPA:LNA)

Jan 23

Should LNA Santé SA (EPA:LNA) Be Part Of Your Dividend Portfolio?

Jan 11

Could The LNA Santé SA (EPA:LNA) Ownership Structure Tell Us Something Useful?

Dec 27

Taking A Look At LNA Santé SA's (EPA:LNA) ROE

Dec 15

LNA Santé SA's (EPA:LNA) Intrinsic Value Is Potentially 71% Above Its Share Price

Dec 02

Here's Why We Think LNA Santé's (EPA:LNA) Statutory Earnings Might Be Conservative

Nov 20

수익 및 매출 성장 예측

ENXTPA:LNA - 애널리스트의 미래 추정치 및 과거 재무 데이터 (EUR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	946	29	101	138	3
12/31/2025	880	27	97	129	3
12/31/2024	797	25	80	115	3
6/30/2024	762	24	108	120	N/A
3/31/2024	749	24	96	109	N/A
12/31/2023	736	23	85	98	N/A
9/30/2023	734	24	68	82	N/A
6/30/2023	732	24	52	66	N/A
3/31/2023	730	25	71	84	N/A
12/31/2022	728	26	90	103	N/A
9/30/2022	720	26	101	114	N/A
6/30/2022	711	26	113	125	N/A
3/31/2022	700	25	90	102	N/A
12/31/2021	689	24	66	80	N/A
9/30/2021	662	20	82	96	N/A
6/30/2021	634	16	98	112	N/A
3/31/2021	604	12	116	129	N/A
12/31/2020	574	8	133	147	N/A
9/30/2020	562	10	119	131	N/A
6/30/2020	551	13	104	115	N/A
3/31/2020	539	17	108	117	N/A
12/31/2019	528	21	112	118	N/A
9/30/2019	531	21	99	107	N/A
6/30/2019	534	22	87	95	N/A
3/31/2019	536	22	63	72	N/A
12/31/2018	539	22	39	48	N/A
9/30/2018	522	23	42	51	N/A
6/30/2018	505	25	45	53	N/A
3/31/2018	496	25	N/A	57	N/A
12/31/2017	487	24	N/A	61	N/A
9/30/2017	492	24	N/A	59	N/A
6/30/2017	497	24	N/A	58	N/A
3/31/2017	486	23	N/A	45	N/A
12/31/2016	475	22	N/A	32	N/A
9/30/2016	449	17	N/A	11	N/A
6/30/2016	423	13	N/A	-10	N/A
3/31/2016	424	12	N/A	5	N/A
12/31/2015	425	11	N/A	20	N/A
9/30/2015	411	10	N/A	36	N/A
6/30/2015	398	9	N/A	52	N/A
3/31/2015	377	8	N/A	29	N/A
12/31/2014	356	7	N/A	7	N/A
9/30/2014	348	8	N/A	7	N/A
6/30/2014	340	8	N/A	7	N/A
3/31/2014	332	8	N/A	15	N/A
12/31/2013	324	8	N/A	23	N/A

애널리스트 미래 성장 예측

수입 대 저축률: LNA's forecast earnings growth (7.5% per year) is above the savings rate (1.2%).

수익 vs 시장: LNA's earnings (7.5% per year) are forecast to grow slower than the French market (12.3% per year).

고성장 수익: LNA's earnings are forecast to grow, but not significantly.

수익 대 시장: LNA's revenue (8.8% per year) is forecast to grow faster than the French market (5.6% per year).

고성장 수익: LNA's revenue (8.8% per year) is forecast to grow slower than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: LNA's Return on Equity is forecast to be low in 3 years time (7.9%).

LNA Santé 미래 성장

Future 기준 확인 2/6

주요 정보

최근 미래 성장 업데이트

Price target decreased by 9.2% to €29.67

Consensus EPS estimates increase by 15%, revenue downgraded

Price target decreased by 12% to €32.67

Price target decreased by 16% to €37.33

Price target decreased to €42.33

Price target decreased to €44.33

Recent updates

First half 2024 earnings released: EPS: €1.21 (vs €1.16 in 1H 2023)

We Think You Can Look Beyond LNA Santé's (EPA:LNA) Lackluster Earnings

Upcoming dividend of €0.60 per share

Investor sentiment improves as stock rises 16%

Price target decreased by 9.2% to €29.67

Consensus EPS estimates increase by 15%, revenue downgraded

LNA Santé SA, Annual General Meeting, Jun 19, 2024

Investor sentiment deteriorates as stock falls 16%

Price target decreased by 12% to €32.67

New minor risk - Earnings quality

Upcoming dividend of €0.50 per share at 1.8% yield

Full year 2022 earnings released: EPS: €2.49 (vs €2.45 in FY 2021)

Price target decreased by 16% to €37.33

Price target decreased to €42.33

Is LNA Santé (EPA:LNA) Using Too Much Debt?

Price target decreased to €44.33

First half 2022 earnings released: EPS: €1.32 (vs €1.16 in 1H 2021)

Price target decreased to €49.00

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to €51.50

Investor sentiment deteriorated over the past week

First half 2021 earnings released: EPS €1.16 (vs €0.26 in 1H 2020)

LNA Santé SA (EPA:LNA) Shares Could Be 43% Below Their Intrinsic Value Estimate

Is LNA Santé (EPA:LNA) Using Too Much Debt?

Consensus EPS estimates increase to €3.00

Earnings Miss: LNA Santé SA Missed EPS By 48% And Analysts Are Revising Their Forecasts

Full year 2020 earnings released

Is LNA Santé SA's (EPA:LNA) 6.9% ROE Strong Compared To Its Industry?

Are Investors Undervaluing LNA Santé SA (EPA:LNA) By 50%?

New 90-day low: €46.70

At €47.80, Is It Time To Put LNA Santé SA (EPA:LNA) On Your Watch List?

Did Business Growth Power LNA Santé's (EPA:LNA) Share Price Gain of 102%?

Our Take On The Returns On Capital At LNA Santé (EPA:LNA)

Should LNA Santé SA (EPA:LNA) Be Part Of Your Dividend Portfolio?

Could The LNA Santé SA (EPA:LNA) Ownership Structure Tell Us Something Useful?

New 90-day high: €50.00

Taking A Look At LNA Santé SA's (EPA:LNA) ROE

LNA Santé SA's (EPA:LNA) Intrinsic Value Is Potentially 71% Above Its Share Price

Here's Why We Think LNA Santé's (EPA:LNA) Statutory Earnings Might Be Conservative

New 90-day low: €45.35

First half earnings released

New 90-day low: €46.25

First half earnings released

New 90-day high - €52.60

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견